- Home
- PIII
as of 10-30-2026 11:45am EST
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 33.8M | IPO Year: | 2021 |
| Target Price: | $18.00 | AVG Volume (30 days): | 13.7K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.27 | EPS Growth: | -4090.74 |
| 52 Week Low/High: | $1.52 - $16.89 | Next Earning Date: | 11-09-2026 |
| Revenue: | $1,459,080,000 | Revenue Growth: | -2.76% |
| Revenue Growth (this year): | 6.32% | Revenue Growth (next year): | 9.37% |
| P/E Ratio: | -16.15 | Index: | N/A |
| Free Cash Flow: | -91238000.0 | FCF Growth: | N/A |
Stock Insider Trading Activity of P3 Health Partners Inc. (PIII)
10% Owner
Avg Cost/Share
$15.43
Shares
50,000
Total Value
$823,927.38
Owned After
48,959
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Hudson Vegas Investment SPV, LLC | PIII | 10% Owner | Aug 10, 2026 | Sell | $15.43 | 50,000 | $823,927.38 | 48,959 |
Earnings Transcripts
SEC 8-K filings with transcript text
2026 Q2 Q2 2026 Earnings
8-K SELL Aug 10, 2026 · 100% conf.
Q2 2026 Earnings
8-K SELLAug 10, 2026 · 100% conf.
1D
-7.12%
$11.60
Act: -0.96%
5D
-12.41%
$10.94
20D
+331.81%
$53.93
Transcript text not available. View on SEC.gov →
2026 Q1 Q1 2026 Earnings
8-K May 14, 2026
Q1 2026 Earnings
8-KMay 14, 2026
2025 Q4 Q4 2025 Earnings
8-K Mar 26, 2026
Q4 2025 Earnings
8-KMar 26, 2026
2025 Q3 Q3 2025 Earnings
8-K Nov 14, 2025
Q3 2025 Earnings
8-KNov 14, 2025
2025 Q2 Q2 2025 Earnings
8-K Aug 14, 2025
Q2 2025 Earnings
8-KAug 14, 2025
2025 Q1 Q1 2025 Earnings
8-K May 15, 2025
Q1 2025 Earnings
8-KMay 15, 2025
2024 Q4 Q4 2024 Earnings
8-K Mar 27, 2025
Q4 2024 Earnings
8-KMar 27, 2025
2024 Q3 Q3 2024 Earnings
8-K Nov 12, 2024
Q3 2024 Earnings
8-KNov 12, 2024
2024 Q2 Q2 2024 Earnings
8-K Aug 7, 2024
Q2 2024 Earnings
8-KAug 7, 2024
2024 Q1 Q1 2024 Earnings
8-K May 8, 2024
Q1 2024 Earnings
8-KMay 8, 2024
2023 Q4 Q4 2023 Earnings
8-K Mar 28, 2024
Q4 2023 Earnings
8-KMar 28, 2024
2023 Q4 Q4 2023 Earnings
8-K Jan 10, 2024
Q4 2023 Earnings
8-KJan 10, 2024
2023 Q3 Q3 2023 Earnings
8-K Nov 8, 2023
Q3 2023 Earnings
8-KNov 8, 2023
2023 Q2 Q2 2023 Earnings
8-K Aug 7, 2023
Q2 2023 Earnings
8-KAug 7, 2023
2023 Q1 Q1 2023 Earnings
8-K May 10, 2023
Q1 2023 Earnings
8-KMay 10, 2023
2022 Q4 Q4 2022 Earnings
8-K Mar 31, 2023
Q4 2022 Earnings
8-KMar 31, 2023
2022 Q4 Q4 2022 Earnings
8-K Mar 15, 2023
Q4 2022 Earnings
8-KMar 15, 2023
2022 Q4 Q4 2022 Earnings
8-K Jan 11, 2023
Q4 2022 Earnings
8-KJan 11, 2023
2022 Q3 Q3 2022 Earnings
8-K Nov 14, 2022
Q3 2022 Earnings
8-KNov 14, 2022
2022 Q3 Q3 2022 Earnings
8-K Oct 20, 2022
Q3 2022 Earnings
8-KOct 20, 2022
Compare PIII vs Leading Stocks
See how PIII stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "PIII P3 Health Partners Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.